Case of the HCV-associated immune thrombocytopenia in patient with chronic hepatitis C

被引：0
|
作者：
Ryabokon, Yu. Yu.
机构：
来源：
PATHOLOGIA | 2012年 / 01期
关键词：
chronic HCV-infection; immune thrombocytopenia;
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
Clinical observation shows a case of the HCV-associated immune thrombocytopenia which is infrequent extrahepatic manifestation of chronic hepatitis C. The case peculiarity is the manifestation of chronic HCV-infection by hemorrhagic syndrome at minimum expressed hepatic manifestations and absence of hepatocirrhosis signs.
引用
收藏
页码：101 / 102
页数：2
相关论文
共 50 条
  • [1] Second Generation Direct-Acting Antiviral Agents Eradicate Hepatitis C Virus (HCV) but Exacerbate Thrombocytopenia in a Patient with HCV-Associated Immune Thrombocytopenic Purpura (ITP): Case Report
    Lee, Le Min
    Johansen, Max E.
    Jy, Wenche
    Horstman, Lawrence L.
    Ahn, Yeon-Soong
    BLOOD, 2014, 124 (21)
  • [2] Role of thrombopoietin in HCV-associated thrombocytopenia
    El-Attar, M.
    Afifi, O.
    Sweffy, E.
    Taie, A.
    LIVER INTERNATIONAL, 2006, 26 : 85 - 85
  • [3] Immunological HCV-Associated Thrombocytopenia: Short Review
    Dimitroulis, Dimitrios
    Valsami, Serena
    Stamopoulos, Paraskevas
    Kouraklis, Gregory
    CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2012,
  • [4] Clearance of Hepatitis C Virus (HCV) Is Associated With Improved Outcomes in HCV-Associated Lymphoma
    Desai, Sanjal H.
    Baez-Sosa, Valentina
    Hameed, Rumaisa
    Al-Shbool, Ghassan
    Fernandez, Stephen
    Vakiti, Anusha
    Stingo, Facundo
    Adhikari, Tripti
    Paku, Emily
    Malkovska, Vera
    Fishbein, Dawn
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (02): : E185 - E193
  • [5] Perihepatic lymph nodes and antiviral response in chronic HCV-associated hepatitis
    Soresi, M
    Bonfissuto, G
    Sesti, R
    Riili, A
    Di Giovanni, G
    Carroccio, A
    Tripi, S
    Montalto, G
    ULTRASOUND IN MEDICINE AND BIOLOGY, 2004, 30 (06): : 711 - 717
  • [6] Improvement of thrombocytopenia with disappearance of HCV RNA in patients treated by interferon-α therapy:: possible etiology of HCV-associated immune thrombocytopenia
    Iga, D
    Tomimatsu, M
    Endo, H
    Ohkawa, SI
    Yamada, O
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2005, 75 (05) : 417 - 423
  • [7] Genotype diversity of hepatitis C virus (HCV) in HCV-associated liver disease patients in Indonesia
    Utama, Andi
    Tania, Navessa Padma
    Dhenni, Rama
    Gani, Rino Alvani
    Hasan, Irsan
    Sanityoso, Andri
    Lelosutan, Syafruddin A. R.
    Martamala, Ruswhandi
    Lesmana, Laurentius Adrianus
    Sulaiman, Ali
    Tai, Susan
    LIVER INTERNATIONAL, 2010, 30 (08) : 1152 - 1160
  • [8] Angiogenic output in viral hepatitis, C and B, and HCV-associated hepatocellular carcinoma
    Mohsen, Mohamed A. Abdel
    Hussein, Neveen A.
    Ghazal, Abeer A.
    El-Ghandour, Marwa K.
    Farouk, Mohamed
    Abd El-Wahab, Abeer E.
    Yousef, Amany I.
    ALEXANDRIA JOURNAL OF MEDICINE, 2014, 50 (03): : 235 - 240
  • [9] Comparative study of hepatitis C virus RNA, histopathology and alanine aminotransferase in HCV-associated hepatitis
    Choi, YJ
    Win, K
    Putti, T
    Remy, P
    Bloom, A
    MODERN PATHOLOGY, 1998, 11 (01) : 62A - 62A
  • [10] HCV-associated fibrosing cholestatic hepatitis (FCH) resolved by DAA treatment in a HIV/HCV-coninfected patient
    Schlabe, S.
    Schneeweiss, S.
    Schwarze-Zander, C.
    Fischer, H. -P.
    Zhou, H.
    Boesecke, C.
    Spengler, U.
    Rockstroh, J. K.
    HIV MEDICINE, 2021, 22 : 302 - 303
12345